Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phloretin is a natural dihydrochalcone flavonoid found in apples, strawberries, and other fruits. It exhibits a range of biological activities including antioxidant, anti-inflammatory, anticancer, antibacterial, and organ-protective effects[1][3][4][5]. Mechanistically, phloretin inhibits glucose transporters SGLT1 and SGLT2 (though less potently than its glycoside phlorizin), reducing intestinal glucose absorption and renal reabsorption[5]. It also inhibits urea transporters and aquaporin 9 (AQP9), modulates the NF-κB signaling pathway to suppress inflammatory cytokines (such as TNF-α, IL-6), induces Nrf2 expression for antioxidant defense[8], increases cell membrane permeability in bacteria leading to antibacterial effects[6], and induces apoptosis in various cancer cell lines by affecting apoptotic proteins such as Bcl-2 family members[7]. Phloretin is primarily studied experimentally for potential therapeutic applications against cancers, diabetes complications (including cardiomyopathy and neuropathy), liver/kidney injury, ulcerative colitis, asthma, arthritis, cognitive impairment as well as microbial infections[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Phloretin.